跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 288 条关于
“Karuna”
全部
288
临床试验
93
药物
29
机构
33
资讯
133
2年前
BMS Acquires Karuna Therapeutics for $14 Billion, Betting on Novel Schizophrenia Drug KarXT
3个月前
Montara Therapeutics Strengthens Leadership with Karuna Founder Andrew Miller, New CMO, and CTO Promotion to Advance Brain-Selective CNS Platform
去年
AbbVie's Emraclidine Fails in Phase II Schizophrenia Trials, Stock Plummets
去年
Syndeio Biosciences Launches with $90M to Target Synaptic Dysfunction in Alzheimer's and Depression
去年
Bristol Myers Squibb's Cobenfy Gains Market Advantage After AbbVie's Schizophrenia Drug Fails Trials
去年
AbbVie's Emraclidine Fails in Phase II Schizophrenia Trials, Stock Plummets
去年
Bristol Myers Squibb Announces $2 Billion Cost-Cutting Plan Amid Patent Cliff Challenges
去年
Denovo Biopharma Forms Neuroscience Advisory Board to Advance Precision Medicine Approach for Treatment-Resistant Depression
去年
Incyte Names Bill Meury as New CEO, Replacing 11-Year Veteran Hervé Hoppenot
去年
Novo Nordisk's Ozempic Faces Safety Review Amidst Major Manufacturing Investments
第 1 页,共 14 页
上一页
下一页